Reducing Dietary Acid With Food Versus Oral Alkali in People With Chronic Kidney Disease (ReDACKD)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Dylan MacKay, PhD
George and Fay Yee Centre for Healthcare Innovation
Principal Investigator - Karthik Tennankore, MD
Nova Scotia Health Authority
Principal Investigator - Navdeep Tangri, MD, PhD
Seven Oaks General Hospital Chronic Disease Innovation Centre
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
2 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Seven Oaks General Hospital Chronic Disease Innovation Centre
Winnipeg, Manitoba, Canada
- Chronic Kidney Disease (renal) Clinicqeii - Dickson Building
Halifax, Nova Scotia, Canada
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 4 Aug 2023
- Primary completion
- 31 Jul 2026
- Completion
- 30 Sept 2026
- Last update posted
- 1 Apr 2026
- Registered enrollment
- 37
- Registry id
- NCT05113641
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.